ARVN - Arvinas GAAP EPS of -$0.97 beats by $0.37 revenue of $25.3M misses by $6.76M
2024-05-07 07:28:22 ET
More on Arvinas
- Arvinas And Novartis Partnering On Prostate Cancer Protein Degrader Is A Win-Win Situation
- Arvinas: Behind The Huge Rally
- Arvinas announces CFO Sean Cassidy's departure
- Citi downgrades Arvinas to neutral, cites valuation
- Seeking Alpha’s Quant Rating on Arvinas